Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Sell
48
MNDR Quote, Financials, Valuation and Earnings
Last price:
$0.92
Seasonality move
:
21.96%
Day range:
$0.90 - $1.10
52-week range:
$1.01 - $40.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.10x
P/B ratio:
1.69x
Volume:
89.8K
Avg. volume:
6.7M
1-year change:
-92.38%
Market cap:
$1.4M
Revenue:
$5.8M
EPS (TTM):
-$0.45
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MNDR
Mobile-health Network Solutions
|
-- | -- | -- | -- | -- |
|
BMGL
Basel Medical Group Ltd.
|
-- | -- | -- | -- | -- |
|
CUPR
Cuprina Holdings (Cayman)
|
-- | -- | -- | -- | -- |
|
GDTC
CytoMed Therapeutics Ltd.
|
$130K | -$0.04 | -- | -- | -- |
|
WVE
Wave Life Sciences Ltd.
|
$10.5M | -$0.30 | -79.56% | -36.52% | $31.60 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MNDR
Mobile-health Network Solutions
|
$1.11 | -- | $1.4M | -- | $0.00 | 0% | 0.10x |
|
BMGL
Basel Medical Group Ltd.
|
$0.53 | -- | $10M | 294.67x | $0.00 | 0% | 1.17x |
|
CUPR
Cuprina Holdings (Cayman)
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
GDTC
CytoMed Therapeutics Ltd.
|
$1.44 | -- | $16.9M | -- | $0.00 | 0% | 97.64x |
|
WVE
Wave Life Sciences Ltd.
|
$17.77 | $31.60 | $3B | -- | $0.00 | 0% | 27.11x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MNDR
Mobile-health Network Solutions
|
-- | -0.831 | -- | 2.20x |
|
BMGL
Basel Medical Group Ltd.
|
-- | 0.000 | -- | -- |
|
CUPR
Cuprina Holdings (Cayman)
|
-- | 0.000 | -- | -- |
|
GDTC
CytoMed Therapeutics Ltd.
|
-- | -0.681 | -- | -- |
|
WVE
Wave Life Sciences Ltd.
|
12.99% | 1.535 | 1.67% | 2.40x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MNDR
Mobile-health Network Solutions
|
-- | -- | -1223.46% | -1223.46% | -- | -- |
|
BMGL
Basel Medical Group Ltd.
|
-- | -- | -- | -- | -- | -- |
|
CUPR
Cuprina Holdings (Cayman)
|
-- | -- | -- | -- | -- | -- |
|
GDTC
CytoMed Therapeutics Ltd.
|
-- | -- | -- | -- | -- | -- |
|
WVE
Wave Life Sciences Ltd.
|
$5.4M | -$56.4M | -64.6% | -73.8% | -740.71% | -$46.1M |
Mobile-health Network Solutions vs. Competitors
-
Which has Higher Returns MNDR or BMGL?
Basel Medical Group Ltd. has a net margin of -- compared to Mobile-health Network Solutions's net margin of --. Mobile-health Network Solutions's return on equity of -1223.46% beat Basel Medical Group Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNDRMobile-health Network Solutions-- -- $4.1M BMGLBasel Medical Group Ltd.-- -- -- -
What do Analysts Say About MNDR or BMGL?
Mobile-health Network Solutions has a consensus price target of --, signalling upside risk potential of 28728.83%. On the other hand Basel Medical Group Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Mobile-health Network Solutions has higher upside potential than Basel Medical Group Ltd., analysts believe Mobile-health Network Solutions is more attractive than Basel Medical Group Ltd..
Company Buy Ratings Hold Ratings Sell Ratings MNDRMobile-health Network Solutions0 0 0 BMGLBasel Medical Group Ltd.0 0 0 -
Is MNDR or BMGL More Risky?
Mobile-health Network Solutions has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Basel Medical Group Ltd. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MNDR or BMGL?
Mobile-health Network Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Basel Medical Group Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mobile-health Network Solutions pays -- of its earnings as a dividend. Basel Medical Group Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNDR or BMGL?
Mobile-health Network Solutions quarterly revenues are --, which are smaller than Basel Medical Group Ltd. quarterly revenues of --. Mobile-health Network Solutions's net income of -- is lower than Basel Medical Group Ltd.'s net income of --. Notably, Mobile-health Network Solutions's price-to-earnings ratio is -- while Basel Medical Group Ltd.'s PE ratio is 294.67x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mobile-health Network Solutions is 0.10x versus 1.17x for Basel Medical Group Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNDRMobile-health Network Solutions0.10x -- -- -- BMGLBasel Medical Group Ltd.1.17x 294.67x -- --
-
Which has Higher Returns MNDR or CUPR?
Cuprina Holdings (Cayman) has a net margin of -- compared to Mobile-health Network Solutions's net margin of --. Mobile-health Network Solutions's return on equity of -1223.46% beat Cuprina Holdings (Cayman)'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNDRMobile-health Network Solutions-- -- $4.1M CUPRCuprina Holdings (Cayman)-- -- -- -
What do Analysts Say About MNDR or CUPR?
Mobile-health Network Solutions has a consensus price target of --, signalling upside risk potential of 28728.83%. On the other hand Cuprina Holdings (Cayman) has an analysts' consensus of -- which suggests that it could fall by --. Given that Mobile-health Network Solutions has higher upside potential than Cuprina Holdings (Cayman), analysts believe Mobile-health Network Solutions is more attractive than Cuprina Holdings (Cayman).
Company Buy Ratings Hold Ratings Sell Ratings MNDRMobile-health Network Solutions0 0 0 CUPRCuprina Holdings (Cayman)0 0 0 -
Is MNDR or CUPR More Risky?
Mobile-health Network Solutions has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Cuprina Holdings (Cayman) has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MNDR or CUPR?
Mobile-health Network Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cuprina Holdings (Cayman) offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mobile-health Network Solutions pays -- of its earnings as a dividend. Cuprina Holdings (Cayman) pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNDR or CUPR?
Mobile-health Network Solutions quarterly revenues are --, which are smaller than Cuprina Holdings (Cayman) quarterly revenues of --. Mobile-health Network Solutions's net income of -- is lower than Cuprina Holdings (Cayman)'s net income of --. Notably, Mobile-health Network Solutions's price-to-earnings ratio is -- while Cuprina Holdings (Cayman)'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mobile-health Network Solutions is 0.10x versus -- for Cuprina Holdings (Cayman). Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNDRMobile-health Network Solutions0.10x -- -- -- CUPRCuprina Holdings (Cayman)-- -- -- --
-
Which has Higher Returns MNDR or GDTC?
CytoMed Therapeutics Ltd. has a net margin of -- compared to Mobile-health Network Solutions's net margin of --. Mobile-health Network Solutions's return on equity of -1223.46% beat CytoMed Therapeutics Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNDRMobile-health Network Solutions-- -- $4.1M GDTCCytoMed Therapeutics Ltd.-- -- -- -
What do Analysts Say About MNDR or GDTC?
Mobile-health Network Solutions has a consensus price target of --, signalling upside risk potential of 28728.83%. On the other hand CytoMed Therapeutics Ltd. has an analysts' consensus of -- which suggests that it could grow by 247.22%. Given that Mobile-health Network Solutions has higher upside potential than CytoMed Therapeutics Ltd., analysts believe Mobile-health Network Solutions is more attractive than CytoMed Therapeutics Ltd..
Company Buy Ratings Hold Ratings Sell Ratings MNDRMobile-health Network Solutions0 0 0 GDTCCytoMed Therapeutics Ltd.0 0 0 -
Is MNDR or GDTC More Risky?
Mobile-health Network Solutions has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison CytoMed Therapeutics Ltd. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MNDR or GDTC?
Mobile-health Network Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CytoMed Therapeutics Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mobile-health Network Solutions pays -- of its earnings as a dividend. CytoMed Therapeutics Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNDR or GDTC?
Mobile-health Network Solutions quarterly revenues are --, which are smaller than CytoMed Therapeutics Ltd. quarterly revenues of --. Mobile-health Network Solutions's net income of -- is lower than CytoMed Therapeutics Ltd.'s net income of --. Notably, Mobile-health Network Solutions's price-to-earnings ratio is -- while CytoMed Therapeutics Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mobile-health Network Solutions is 0.10x versus 97.64x for CytoMed Therapeutics Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNDRMobile-health Network Solutions0.10x -- -- -- GDTCCytoMed Therapeutics Ltd.97.64x -- -- --
-
Which has Higher Returns MNDR or WVE?
Wave Life Sciences Ltd. has a net margin of -- compared to Mobile-health Network Solutions's net margin of -707.83%. Mobile-health Network Solutions's return on equity of -1223.46% beat Wave Life Sciences Ltd.'s return on equity of -73.8%.
Company Gross Margin Earnings Per Share Invested Capital MNDRMobile-health Network Solutions-- -- $4.1M WVEWave Life Sciences Ltd.70.69% -$0.32 $152.2M -
What do Analysts Say About MNDR or WVE?
Mobile-health Network Solutions has a consensus price target of --, signalling upside risk potential of 28728.83%. On the other hand Wave Life Sciences Ltd. has an analysts' consensus of $31.60 which suggests that it could grow by 77.83%. Given that Mobile-health Network Solutions has higher upside potential than Wave Life Sciences Ltd., analysts believe Mobile-health Network Solutions is more attractive than Wave Life Sciences Ltd..
Company Buy Ratings Hold Ratings Sell Ratings MNDRMobile-health Network Solutions0 0 0 WVEWave Life Sciences Ltd.13 0 0 -
Is MNDR or WVE More Risky?
Mobile-health Network Solutions has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Wave Life Sciences Ltd. has a beta of -1.719, suggesting its less volatile than the S&P 500 by 271.88%.
-
Which is a Better Dividend Stock MNDR or WVE?
Mobile-health Network Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Wave Life Sciences Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mobile-health Network Solutions pays -- of its earnings as a dividend. Wave Life Sciences Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNDR or WVE?
Mobile-health Network Solutions quarterly revenues are --, which are smaller than Wave Life Sciences Ltd. quarterly revenues of $7.6M. Mobile-health Network Solutions's net income of -- is lower than Wave Life Sciences Ltd.'s net income of -$53.9M. Notably, Mobile-health Network Solutions's price-to-earnings ratio is -- while Wave Life Sciences Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mobile-health Network Solutions is 0.10x versus 27.11x for Wave Life Sciences Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNDRMobile-health Network Solutions0.10x -- -- -- WVEWave Life Sciences Ltd.27.11x -- $7.6M -$53.9M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
89
GDXU alert for Dec 30
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 18.81% over the past day.
Sell
20
SMX alert for Dec 30
SMX (Security Matters) Plc [SMX] is down 27.67% over the past day.
Buy
72
GLTO alert for Dec 30
Galecto, Inc. [GLTO] is down 12.13% over the past day.
